Cronos (CRON) Capital Expenditures Growth (1y) (2020 - 2026)
Cronos (CRON) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | -54.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.68% |
| Mar 31, 2026 | -87.71% |
| Dec 31, 2025 | -39.63% |
| Sep 30, 2025 | -30.12% |
| Jun 30, 2025 | 426.34% |
| Mar 31, 2025 | 785.03% |
| Dec 31, 2024 | 190.89% |
| Sep 30, 2024 | 9,474.63% |
| Jun 30, 2024 | 47.57% |
| Mar 31, 2024 | 114.43% |
| Dec 31, 2023 | 234.62% |
| Sep 30, 2023 | -49.62% |
| Jun 30, 2023 | -67.22% |
| Mar 31, 2023 | 13.08% |
| Dec 31, 2022 | -26.17% |
| Sep 30, 2022 | -94.23% |
| Jun 30, 2022 | -9.60% |
| Mar 31, 2022 | -89.36% |
| Dec 31, 2021 | -95.11% |
| Sep 30, 2021 | -71.16% |